Close this search box.
Close this search box.

Theranos CEO Holmes Presses on as Costs Mount

Recent court settlements have given Holmes more room to focus on product development, though hurdles remain.

The financial impact of Theranos’ disputes with authorities, partners and customers accumulated this week following two settlements that cost the blood-testing company almost $5 million.

The upshot was that it held onto its lab-operating certificates, posing the question of whether founder and CEO Elizabeth Holmes will ever fully recover from the scandal that started in 2015 when the Wall Street Journal first suggested the company’s products were flawed.

On Monday, Theranos agreed to drop its appeal against a ruling last year by the Centers for Medicare & Medicaid Services banning it from operating a clinical laboratory for two years. The authority also withdrew the revocation of its CLIA operating certificates and only imposed a relatively modest $30,000 fine.

A day later, Theranos agreed to pay a $4.65 million settlement to cover full refunds for every customer in Arizona that used the company’s testing services. Theranos also agreed to pay $200,000 in civil penalties and $25,000 in attorney’s fees, though, as the company noted in a statement, the matter was settled without any admission of liability.


In a separate statement, the company suggested its future could get brighter.

“Theranos exited the clinical lab and retail business last year, and is focusing on its miniaturized, automated testing platforms and related chemistries,” it said. “The company looks forward to working with regulatory authorities to secure approval for these innovative technologies.”

Last August, Holmes unveiled a new “mini-lab” kit that can run a variety of diagnostic tests on small-volume blood samples. It is still awaiting approval from the U.S. Food & Drug Administration.

In the meantime, Theranos will have to contend with looming lawsuits that could place more strain on its balance sheet. Walgreens, for example, is seeking $140 million in damages from its former partner and some investors also have sued the company.

So it looks like it’s a race against the clock to see if Theranos can get FDA approval and start generating some revenue or extra funding before its money runs out.

Even if the firm does get the regulator’s blessing, Holmes will have to convince a skeptical public exposed to almost two years of negative press that Theranos’ products and practices are sound.

You might also like:
5 Lessons for a Corporate Turnaround from an Auto Industry CEO
7 Turnaround Tips From an Interim CEO
Boards: Choose a CEO for Long-Term Growth, Not Just a Turnaround
8 Leadership Tactics From a CEO Who Orchestrated a Successful Turnaround


  • Get the CEO Briefing

    Sign up today to get weekly access to the latest issues affecting CEOs in every industry
  • upcoming events


    Strategic Planning Workshop

    1:00 - 5:00 pm

    Over 70% of Executives Surveyed Agree: Many Strategic Planning Efforts Lack Systematic Approach Tips for Enhancing Your Strategic Planning Process

    Executives expressed frustration with their current strategic planning process. Issues include:

    1. Lack of systematic approach (70%)
    2. Laundry lists without prioritization (68%)
    3. Decisions based on personalities rather than facts and information (65%)


    Steve Rutan and Denise Harrison have put together an afternoon workshop that will provide the tools you need to address these concerns.  They have worked with hundreds of executives to develop a systematic approach that will enable your team to make better decisions during strategic planning.  Steve and Denise will walk you through exercises for prioritizing your lists and steps that will reset and reinvigorate your process.  This will be a hands-on workshop that will enable you to think about your business as you use the tools that are being presented.  If you are ready for a Strategic Planning tune-up, select this workshop in your registration form.  The additional fee of $695 will be added to your total.

    To sign up, select this option in your registration form. Additional fee of $695 will be added to your total.

    New York, NY: ​​​Chief Executive's Corporate Citizenship Awards 2017

    Women in Leadership Seminar and Peer Discussion

    2:00 - 5:00 pm

    Female leaders face the same issues all leaders do, but they often face additional challenges too. In this peer session, we will facilitate a discussion of best practices and how to overcome common barriers to help women leaders be more effective within and outside their organizations. 

    Limited space available.

    To sign up, select this option in your registration form. Additional fee of $495 will be added to your total.

    Golf Outing

    10:30 - 5:00 pm
    General’s Retreat at Hermitage Golf Course
    Sponsored by UBS

    General’s Retreat, built in 1986 with architect Gary Roger Baird, has been voted the “Best Golf Course in Nashville” and is a “must play” when visiting the Nashville, Tennessee area. With the beautiful setting along the Cumberland River, golfers of all capabilities will thoroughly enjoy the golf, scenery and hospitality.

    The golf outing fee includes transportation to and from the hotel, greens/cart fees, use of practice facilities, and boxed lunch. The bus will leave the hotel at 10:30 am for a noon shotgun start and return to the hotel after the cocktail reception following the completion of the round.

    To sign up, select this option in your registration form. Additional fee of $295 will be added to your total.